Midwest Medcl Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MIDWEST MEDCL
MIDWEST MEDCL has three approved drugs.
Drugs and US Patents for Midwest Medcl
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Midwest Medcl | FLUDEOXYGLUCOSE F18 | fludeoxyglucose f-18 | INJECTABLE;INTRAVENOUS | 203736-001 | Nov 19, 2015 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Midwest Medcl | SODIUM FLUORIDE F-18 | sodium fluoride f-18 | INJECTABLE;INTRAVENOUS | 204440-001 | Nov 17, 2015 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Midwest Medcl | AMMONIA N 13 | ammonia n-13 | INJECTABLE;INTRAVENOUS | 204457-001 | Nov 18, 2015 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

